Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis

Abstract

The soluble cluster of differentiation 14 (or presepsin) is a free fragment of glycoprotein expressed on monocytes and macrophages. Although many studies have been conducted recently, the diagnostic performance of presepsin for sepsis remains debated. We performed a systematic review and meta-analysis of the available literature to assess the accuracy of presepsin for the diagnosis of sepsis in adult patients and compared the performance between presepsin, C-reactive protein (CRP), and procalcitonin (PCT). A comprehensive systemic search was conducted in PubMed, EMBASE, and Google Scholar for studies that evaluated the diagnostic accuracy of presepsin for sepsis until January 2017. The hierarchical summary receiver operating characteristic method was used to pool individual sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and area under the receiver operating characteristic curve (AUC). Eighteen studies, comprising 3470 patients, met our inclusion criteria. The pooled diagnosis sensitivity and specificity of presepsin for sepsis were 0.84 (95% CI 0.80–0.87) and 0.76 (95% CI 0.67–0.82), respectively. Furthermore, the pooled DOR, PLR, NLR, and AUC were 16 (95% CI 10–25), 3.4 (95% CI 2.5–4.6), 0.22 (95% CI 0.17–0.27), and 0.88 (95% CI 0.85–0.90), respectively. Significant heterogeneity was found in both sensitivities (Cochrane Q = 137.43, p < 0.001, I 2 = 87.63%) and specificities (Cochrane Q = 180.76, p < 0.001, I 2 = 90.60%). Additionally, we found no significant difference between presepsin and PCT (AUC 0.87 vs. 0.86) or CRP (AUC 0.85 vs. 0.85). However, for studies conducted in ICU, the pooled sensitivity of presepsin was found to be higher than PCT (0.88, 95% CI 0.82–0.92 vs. 0.75, 95% CI 0.68–0.81), while the pooled specificity of presepsin was lower than PCT (0.58, 95% CI 0.42–0.73 vs. 0.75, 95% CI 0.65–0.83). Based on the results of our meta-analysis, presepsin is a promising marker for diagnosis of sepsis as PCT or CRP, but its results should be interpreted more carefully and cautiously since too few studies were included and those studies had high heterogeneity between them. In addition, continuing re-evaluation during the course of sepsis is advisable.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 53

1. 1.

   Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-19.

   Not in our library10.5847/wjem.j.issn.1920-8642.2014.01.002 (opens in a new tab)

2. 2.

   Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351(1–2):17-29.

   Not in our library10.1016/j.cccn.2004.08.018 (opens in a new tab)

3. 3.

   Chen KF, Chaou CH, Jiang JY, Yu HW, Meng YH, Tang WC, Wu CC. Diagnostic accuracy of lipopolysaccharide-binding protein as biomarker for sepsis in adult patients: a systematic review and meta-analysis. PLoS ONE. 2016;11(4):e0153188.

   Not in our library10.1371/journal.pone.0153188 (opens in a new tab)

4. 4.

   Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohe J, Lepape A, Monneret G. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med. 2009;35(11):1859-1867.

   Not in our library10.1007/s00134-009-1610-5 (opens in a new tab)

5. 5.

   Lu YH, Liu L, Qiu XH, Yu Q, Yang Y, Qiu HB. Effect of early goal directed therapy on tissue perfusion in patients with septic shock. World J Emerg Med. 2013;4(2):117-122.

   Not in our library10.5847/wjem.j.issn.1920-8642.2013.02.006 (opens in a new tab)

6. 6.

   Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med. 2008;34(11):2084-2091.

   Not in our library10.1007/s00134-008-1173-x (opens in a new tab)

7. 7.

   Wu HP, Chen CK, Chung K, Jiang BY, Yu TJ, Chuang DY. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity. J Formos Med Assoc. 2009;108(1):20-27.

   Not in our library10.1016/s0929-6646(09)60028-0 (opens in a new tab)

8. 8.

   Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552.

   Not in our library10.1097/ccm.0000000000002255 (opens in a new tab)

9. 9.

   Julian-Jimenez A, Candel-Gonzalez FJ, Gonzalez Del Castillo J. Usefulness of inflammation and infection biomarkers in the Emergency Department. Enferm Infecc Microbiol Clin. 2014;32(3):177-190.

   Not in our library10.1016/j.eimc.2013.01.005 (opens in a new tab)

10. 10.

    Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):ii33-ii40.

    Not in our library10.1093/jac/dkq523 (opens in a new tab)

11. 11.

    Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210-217.

    Not in our library10.1016/s1473-3099(07)70052-x (opens in a new tab)

12. 12.

    Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.

    Not in our library10.1016/s1473-3099(12)70323-7 (opens in a new tab)

13. 13.

    Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001;38(2–3):189-197.

    Not in our library10.1016/s0161-5890(01)00042-6 (opens in a new tab)

14. 14.

    Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412(23–24):2157-2161.

    Not in our library10.1016/j.cca.2011.07.024 (opens in a new tab)

15. 15.

    Gong XW, Jiang Y. Structure, function and modulation of actin-related protein 2/3 complex. Sheng Li Ke Xue Jin Zhan. 2004;35(4):306-310.

    Not in our library

16. 16.

    Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med. 2011;24(Suppl 2):12-14.

    Not in our library10.3109/14767058.2011.601923 (opens in a new tab)

17. 17.

    Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764-769.

    Not in our library10.1007/s10156-011-0254-x (opens in a new tab)

18. 18.

    Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med. 2011;49(5):937-939.

    Not in our library10.1515/cclm.2011.145 (opens in a new tab)

19. 19.

    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-1012.

    Not in our library10.1016/j.jclinepi.2009.06.005 (opens in a new tab)

20. 20.

    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.

    Not in our library10.2307/2529310 (opens in a new tab)

21. 21.

    Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536.

    Not in our library10.7326/0003-4819-155-8-201110180-00009 (opens in a new tab)

22. 22.

    Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865-2884.

    Not in our library10.1002/sim.942 (opens in a new tab)

23. 23.

    Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12(14):1293-1316.

    Not in our library10.1002/sim.4780121403 (opens in a new tab)

24. 24.

    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.

    Not in our library10.1002/sim.1186 (opens in a new tab)

25. 25.
    Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment · 2014

    No notice
26. 26.

    Brenner T, Fleming T, Uhle F, Silaff S, Schmitt F, Salgado E, Ulrich A, Zimmermann S, Bruckner T, Martin E, et al. Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study. Crit Care. 2014;18(6):683.

    Not in our library10.1186/s13054-014-0683-x (opens in a new tab)

27. 27.

    Cakir Madenci O, Yakupoglu S, Benzonana N, Yucel N, Akbaba D, Orcun Kaptanagasi A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 2014;40(4):664-669.

    Not in our library10.1016/j.burns.2013.08.024 (opens in a new tab)

28. 28.

    Carpio R, Zapata J, Spanuth E, Hess G. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Clin Chim Acta. 2015;450:169-175.

    Not in our library10.1016/j.cca.2015.08.013 (opens in a new tab)

29. 29.

    Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891-897.

    Not in our library10.1007/s10156-012-0435-2 (opens in a new tab)

30. 30.

    Godnic M, Stubljar D, Skvarc M, Jukic T. Diagnostic and prognostic value of sCD14-ST–presepsin for patients admitted to hospital intensive care unit (ICU). Wien Klin Wochenschr. 2015;127(13–14):521-527.

    Not in our library10.1007/s00508-015-0719-5 (opens in a new tab)

31. 31.

    Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J, Umemura T. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit Care. 2014;18(1):R19.

    Not in our library10.1186/cc13700 (opens in a new tab)

32. 32.

    Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J Crit Care. 2014;29(6):965-970.

    Not in our library10.1016/j.jcrc.2014.06.014 (opens in a new tab)

33. 33.
    Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department · 2013

    No notice
34. 34.

    Nakamura Y, Ishikura H, Nishida T, Kawano Y, Yuge R, Ichiki R, Murai A. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiol. 2014;14:88.

    Not in our library10.1186/1471-2253-14-88 (opens in a new tab)

35. 35.

    Romualdo LG, Torrella PE, Gonzalez MV, Sanchez RJ, Holgado AH, Freire AO, Acebes SR, Oton MD. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014;47(7–8):505-508.

    Not in our library10.1016/j.clinbiochem.2014.02.011 (opens in a new tab)

36. 36.

    Sargentini V, Ceccarelli G, D’Alessandro M, Collepardo D, Morelli A, D’Egidio A, Mariotti S, Nicoletti AM, Evangelista B, D’Ettorre G, et al. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Clin Chem Lab Med. 2015;53(4):567-573.

    Not in our library10.1515/cclm-2014-0119 (opens in a new tab)

37. 37.

    Takahashi G, Shibata S, Ishikura H, Miura M, Fukui Y, Inoue Y, Endo S. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study. Eur J Anaesthesiol. 2015;32(3):199-206.

    Not in our library10.1097/eja.0000000000000178 (opens in a new tab)

38. 38.
    Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study · 2013

    No notice
39. 39.

    Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med. 2013;51(10):2053-2062.

    Not in our library10.1515/cclm-2013-0061 (opens in a new tab)

40. 40.

    de Guadiana Romualdo LG, Torrella PE, Acebes SR, Oton MD, Sanchez RJ, Holgado AH, Santos EJ, Freire AO. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department. Clin Chim Acta. 2016;464:6-11.

    Not in our library10.1016/j.cca.2016.11.003 (opens in a new tab)

41. 41.

    Klouche K, Cristol JP, Devin J, Gilles V, Kuster N, Larcher R, Amigues L, Corne P, Jonquet O, Dupuy AM. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016;6(1):59.

    Not in our library10.1186/s13613-016-0160-6 (opens in a new tab)

42. 42.

    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-1655.

    Not in our library10.1378/chest.101.6.1644 (opens in a new tab)

43. 43.

    Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-810.

    Not in our library10.1001/jama.2016.0287 (opens in a new tab)

44. 44.

    Orta Mira N, Guna Serrano Mdel R, Perez JL, Gimeno Cardona C. Quality assessment program of the Spanish Society of Infectious Diseases and Clinical Microbiology. Analysis of results. 2005. Enferm Infecc Microbiol Clin. 2006;24(Suppl 1):1-7.

    Not in our library10.1157/13094271 (opens in a new tab)

45. 45.

    Greenhalgh DG, Saffle JR, Holmes JHT, Gamelli RL, Palmieri TL, Horton JW, Tompkins RG, Traber DL, Mozingo DW, Deitch EA, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776-790.

    Not in our library10.1097/bcr.0b013e3181599bc9 (opens in a new tab)

46. 46.

    Tong X, Cao Y, Yu M, Han C. Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis. Ther Clin Risk Manag. 2015;11:1027-1033.

    Not in our library10.2147/tcrm.s84811 (opens in a new tab)

47. 47.

    Wu J, Hu L, Zhang G, Wu F, He T. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS ONE. 2015;10(7):e0133057.

    Not in our library10.1371/journal.pone.0133057 (opens in a new tab)

48. 48.

    Zhang J, Hu ZD, Song J, Shao J. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(47):e2158.

    Not in our library10.1097/md.0000000000002158 (opens in a new tab)

49. 49.

    Zhang X, Liu D, Liu YN, Wang R, Xie LX. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care. 2015;19:323.

    Not in our library10.1186/s13054-015-1032-4 (opens in a new tab)

50. 50.

    Zheng Z, Jiang L, Ye L, Gao Y, Tang L, Zhang M. The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis. Ann Intensive Care. 2015;5(1):48.

    Not in our library10.1186/s13613-015-0089-1 (opens in a new tab)

51. 51.

    Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, Okamura Y, Miyamoto D. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem. 2008;375(1):144-146.

    Not in our library10.1016/j.ab.2007.12.030 (opens in a new tab)

52. 52.

    Bossink AW, Groeneveld AB, Thijs LG. Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis. 1999;29(2):398-407.

    Not in our library10.1086/520222 (opens in a new tab)

53. 53.

    Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498-504.

    Not in our library10.1097/00003246-199903000-00024 (opens in a new tab)

Cited by papers we hold 2

• The Pathogenesis of Sepsis and Potential Therapeutic Targets · 2019
  No notice
• The role of presepsin in the diagnosis and assessment of severity of sepsis and severe pneumonia · 2018
  Not checked

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.